MILabs

Clarity that advances discovery

MILabs empowers researchers to see biology with depth and confidence, producing reliable, reproducible insight that strengthens scientific discovery and drives real-world impact.

With decades of scientific leadership and a track record of high-resolution innovation, MILabs helps teams visualize meaningful signals, quantify complex biological processes, and generate evidence that holds up across studies. Through flexible molecular and anatomical imaging configurations, a streamlined workflow, and close scientific partnership, MILabs reduces complexity while supporting stronger outcomes.

Discover MILabs

See biological processes with greater clarity and confidence

Thanks to MILabs’ high-resolution imaging solutions, researchers can visualize tracer behavior, quantify signals, and generate reliable, reproducible insight across diverse research areas.

Discover Imaging Solutions

Clearer insight with less friction

MILabs brings molecular and anatomical imaging together in a scalable workflow, so researchers can build the configuration they need today and evolve it as new questions emerge. A unified software experience helps teams capture and reconstruct data consistently across modalities, reducing variability, simplifying training, and supporting reliable, reproducible outcomes across studies.

Discover Technologies

Imaging for a wide range of study designs

Whether you’re exploring neurobiology, oncology, cardiovascular systems, tracer development, or emerging research areas, MILabs helps you generate the evidence you need with clarity and reproducibility. Flexible imaging configurations and unified workflows support a wide range of study designs, helping research teams work efficiently and build stronger conclusions.

Discover Applications

Hear from the experts

Simultaneous SPECT imaging of neurotransmitter systems in the brain

Name and title - Dr. Kelly Ceyzériat, Hôpitaux Universitaires de Genève

In this webinar, Dr. Kelly Ceyzériat, Hôpitaux Universitaires de Genève, explains how the U-SPECT imaging system helps researchers estimate both density and affinity of dopaminergic receptors in the striatum, ventral tegmental area, and substantia nigra. By studying two neurotransmitter systems within a single acquisition, researchers can evaluate interactions between them while improving efficiency and data consistency.
Discover more

Imaging heterogeneous oncolytic virus spread in tumors at Mayo Clinic

Name and title - Dr. Peng, professor at Mayo Clinic

“In order to see the viral spread inside a tumor in a treated animal, we use the U-SPECT/CT system because it provides us with extremely high-resolution SPECT images (0.25 mm). This enables us to track the expansion of individual infectious centers of a NIS-expressing oncolytic virus in a single tumor nodule.”
Discover more

Resources

See how researchers worldwide use MILabs imaging to validate findings and advance scientific understanding. Explore peer-reviewed studies, technical articles, white papers, and real-world examples that highlight what MILabs systems make possible across research disciplines.

Go to Resources

Peer-to-peer expert partnerships

Count on support from trained application and service specialists who minimize downtime and enable researchers to keep their studies running efficiently and on schedule through personal, cross-disciplinary collaboration.

Go to Support

Upcoming events

Connect with the MILabs team at leading scientific conferences, workshops, and industry events.

All Events
No events found.
No events found.
All Events

News & Updates

Explore announcements, customer stories, technology updates, and highlights from the scientific community.

More News
December 9, 2010 | Press Release

MILabs and Mid-Atlantic Imaging Services announce strategic support agreement for the US and Canada

MILabs, B.V. the Netherlands-based innovator and manufacturer of pre-clinical SPECT/PET/CT imaging devices used in biological and pharmaceutical research today announces a strategic service and support agreement with Mid-Atlantic Imaging Services of Columbia, MD. As part of MILabs growth and expansion plans for the Americas market, Mid-Atlantic Imaging Services will partner with MILabs to provide installation and first response service support to MILabs customers in the US and Canada.
Read more
September 6, 2010 | News

Frost & Sullivan Product Innovation Award for VECTor

The Frost & Sullivan Best Practices team has presented MILabs with the 2010 New Product Innovation Award for VECTor. In their analysis MILabs is recognized as a rapidly growing company standing out among the players in the Preclinical Imaging market with world-class products. MILabs’ proprietary VECTor technology provides fully integrated simultaneous SPECT and PET imaging with sub-mm resolution. In numerous molecular imaging applications VECTor surpasses the resolution capabilities of both classical coincidence PET and competing SPECT technologies.
Read more
May 31, 2009 | Press Release

Press release: TU Delft and MILabs merge PET and SPECT biomedical imaging techniques

TU Delft and MILabs merge PET and SPECT biomedical imaging techniques and deliver increased resolution TU Delft and Molecular Imaging Labs (MILabs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. These techniques are particularly useful for cancer research. The two techniques are known as microPET and microSPECT. SPECT and PET can be performed simultaneously and they give a higher resolution than traditional microSPECT and microPET. The new device is known as the VECTor (Versatile Emission Computed Tomography) and is designed for use in fundamental research into the functioning of cells and organs. It can show functional details smaller than half a millimetre.
Read more
No results found.
More News